Jean-Pierre Gillet

Jean-Pierre Gillet is a researcher at the University of Namur's URPHYM institute, specializing in molecular mechanisms of cancer multidrug resistance and ABC transporter biology. With a Doctor of Science degree focused on microarray-based detection of drug resistance biomarkers and lymphoma characterization, he leads projects on cancer therapy targets like ABCB5 isoforms and circulating tumor DNA diagnostics.

His research spans

• Molecular oncology
• Pharmacogenomics
• Protein transporter function
• Venom peptide drug development

Recent publications highlight ABCB5's role in melanoma, structural dynamics of P-glycoprotein domains, and venom peptides for novel therapeutics. Collaborations include the University of Liverpool and US National Cancer Institute.

Scientific accolades:

• Adrien Bauchau Award (2005)
• NCI Intramural Innovation Award (2010)
• Eppendorf Fellowship (2004)
• Erasmus mobility grants

Active in academic service as a Federal Agency for Medicines expert, F1000Prime faculty member, and jury member for childhood cancer foundations, he continues translational research while mentoring students and postdocs.